Warner Bros Discovery, Inc. Kaplan Fox & Kilsheimer LLP is Investigating Warner Bros. Discovery, Inc. (WBD) for Potential Securities Law Violations… Read MoreJoin Investigation
New Fortress Energy Inc. Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against New Fortress Energy Inc. (NFE) (“New Fortress” or the “Company”) (NASDAQ: NFE)…. Read MoreJoin Investigation
LegalZoom.com Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against LegalZoom.com (“LegalZoom” or the “Company”) (NASDAQ: LZ)…. Read MoreJoin Investigation
Napco Security Technologies, Inc. Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC)…. Read MoreJoin Investigation
Grifols SA Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQ: GRFS)…. Read MoreJoin Investigation
Cardlytics, Inc. Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cardlytics, Inc. (CDLX) (“Cardlytics” or the “Company”) (NASDAQ: CDLX)…. Read MoreJoin Investigation
Digital Currency Group, Inc. On November 13, 2023, Lead Plaintiffs filed an amended complaint against Digital Currency Group, Inc., Barry Silbert, Glenn Hutchins, Lawrence Lenihan, Michael Kraines, Mark Murphy, Soichiro “Michael” Moro, and Derar Islim alleging violations of the Securities Act of 1933, the Securities Exchange Act of 1934, and violations of New York and Connecticut consumer protection statutes. A copy of the November 13, 2023 amended complaint can be viewed here…. Read More
Spectrum Pharmaceuticals, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a proposed class action suit in the United States District Court for the Southern District of New York against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NasdaqGS: SPPI), Thomas J. Riga, the Company’s Chief Executive Officer, and a member of the Company’s Board of Directors, Francois J. Lebel, the Company’s Chief Medical Officer, and Nora E. Brennan, the Company’s Chief Financial Officer. … Read More
